Publications by authors named "G Zuccarini"

The impairment of development/migration of hypothalamic gonadotropin-releasing hormone (GnRH) neurons is the main cause of Kallmann's syndrome (KS), an inherited disorder characterized by hypogonadism, anosmia, and other developmental defects. Olfactorin is an extracellular matrix protein encoded by the (uromodulin-like 1) gene expressed in the mouse olfactory region along the migratory route of GnRH neurons. It shares a combination of WAP and FNIII repeats, expressed in complementary domains, with anosmin-1, the product of the gene, identified as the causative of KS.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the impact of interfering with cannabinoid receptor type 1 (CB1R) on the development of specific brain neurons that regulate reproduction and appetite.
  • The research utilized zebrafish models to observe changes in GnRH3 and AgRP1 neurons when CB1R was pharmacologically or genetically disrupted, leading to fewer neurons and misrouted connections.
  • Findings suggest that exposure to low doses of compounds that affect CB1R during embryonic development could adversely influence neuroendocrine functions crucial for sexual maturation and food intake.
View Article and Find Full Text PDF

Acrofrontofacionasal Dysostosis type 1 (AFFND1) is an extremely rare, autosomal recessive syndrome, comprising facial and skeletal abnormalities, short stature and intellectual disability. We analyzed an Indian family with two affected siblings by exome sequencing and identified a novel homozygous truncating mutation in the Neuroblastoma-Amplified Sequence (NBAS) gene in the patients' genome. Mutations in the NBAS gene have recently been associated with different phenotypes mainly involving skeletal formation, liver and cognitive development.

View Article and Find Full Text PDF

Interstitial lung disease (ILD) may be caused by a wide panel of recognized drugs. Despite the increasing number of reports in the literature, high-lightings of ILD related to oral hypoglycemic drugs are very infrequent.  Herein, we describe the case of a 78-yr-old Caucasian diabetic woman who developed mild dyspnoea at rest, asthenia and fever while on treatment with oral metformin (2000 mg/day) and glibenclamide (12.

View Article and Find Full Text PDF